Ptosis, commonly known as droopy eyelids, affects millions of people worldwide. It not only alters one’s appearance but can also impair vision and lead to discomfort and frustration. Until recently, lid surgery, or blepharoplasty, has been the only way to alleviate ptosis. But blepharoplasty is expensive and isn’t right for everyone. Fortunately, Upneeq offers another option

Why Droopy Eyelids Suck?

Droopy eyelids, or ptosis, occur when the upper eyelid droops over the eye, partially obstructing vision. This can result from various causes, including aging, muscle weakness, nerve damage, or congenital factors. While some cases may be mild and asymptomatic, severe ptosis can significantly impact daily life, hindering tasks like reading, driving, and even facial expressions.

Historically, surgical intervention has been the primary treatment for severe ptosis. Individuals with mild to moderate ptosis were not always candidates. Even if the patient is a candidate for blepharoplasty, the surgery can be risky and cost-prohibitive. 

Introducing Upneeq:

Upneeq (oxymetazoline hydrochloride ophthalmic solution) represents a paradigm shift in the management of ptosis. Approved by the U.S. Food and Drug Administration (FDA) in 2020, Upneeq offers a non-invasive, convenient alternative to surgical correction. It works by stimulating the Müller’s muscle, responsible for elevating the eyelid, leading to temporary improvement in eyelid position and opening.

Advantages of Upneeq:

Upneeq offers several advantages over traditional surgical options:

  1. Non-Invasive: Unlike surgery, Upneeq is administered as eye drops, eliminating the need for incisions or anesthesia.
  2. Quick Onset: Patients experience a noticeable improvement in eyelid position within minutes of application.
  3. Minimal Side Effects: Upneeq is generally well-tolerated, with mild and transient side effects such as eye irritation or redness reported infrequently.
  4. Convenience: The portable nature of Upneeq makes it a convenient option for on-the-go use, allowing patients to address ptosis symptoms whenever needed.

Clinical Efficacy:

Clinical trials have demonstrated the efficacy of Upneeq in improving eyelid position and patient satisfaction. In a pivotal Phase 3 study, Upneeq was shown to significantly increase the margin reflex distance (MRD), a measure of eyelid elevation, compared to placebo. Moreover, patients reported high levels of satisfaction with the treatment, citing improvements in both functional and cosmetic outcomes.

Upneeq represents a significant advancement in the management of ptosis, offering a safe, effective, and convenient alternative to surgical correction. Its ability to quickly and temporarily lift droopy eyelids provides patients with greater control over their symptoms and enhances their quality of life. As research and development continue to drive innovation in ophthalmic care, Upneeq stands as a shining example of how science can transform lives, one blink at a time. 

Book your eye exam to try Upneeq today!

Upneeq drops for droopy lids santa monica

Leave a Reply

Your email address will not be published. Required fields are marked *